Английская Википедия:Amrubicin

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Amrubicin (INN; previously known as SM-5887) is an anthracycline used in the treatment of lung cancer.[1] It is marketed in Japan since 2002 by Sumitomo under the brand name Calsed.[2]

Amrubicin acts by inhibiting topoisomerase II, and has been compared in clinical trials with topotecan, a Topoisomerase I inhibitor.[3][4]

It has also been studied for the treatment of bladder carcinoma[5] and gastric cancer.[6]

Amrubicin was the first anthracycline derivative created by de novo synthesis and was first published in 1989 by scientists from Sumitomo.[7]

References

Шаблон:Reflist

Шаблон:Chemotherapeutic agents


Шаблон:Antineoplastic-drug-stub

  1. Шаблон:Cite journal
  2. Шаблон:Cite web Шаблон:Dead link
  3. Шаблон:Cite web
  4. Шаблон:Cite web
  5. Шаблон:Cite journal
  6. Шаблон:Cite journal
  7. Hanada M. Amrubicin, Chapter 6 in Case Studies in Modern Drug Discovery and Development. Eds. Huang X and Aslanian RG. John Wiley & Sons, 2012 Шаблон:ISBN P 106